Skip to main content
Top
Published in: Rheumatology International 7/2009

01-05-2009 | Original Article

Association of macroscopic gut inflammation with disease activity, functional status and quality of life in ankylosing spondylitis

Authors: Gulen Hascelik, Bengi Oz, Nese Olmez, Asuman Memis, Gazi Yoruk, Belkıs Unsal, Nese Ekinci

Published in: Rheumatology International | Issue 7/2009

Login to get access

Abstract

The aim of this cross-sectional study was to evaluate the frequency of intestinal inflammation and its association with disease activity, functional status and quality of life in patients with ankylosing spondylitis (AS). A total of 25 patients with AS had undergone ileocolonoscopy and concomitant histological study. Clinical and demographical parameters, BASDAI, BASFI, and SF-36 scores were compared between patients with and without macroscopic gut inflammation (MGI). Colonoscopic study revealed MGI in 9 patients and macroscopically normal gut mucosa in 16 patients. On histological examination, of 25 patients 20 had gut inflammation, mostly in ileum. BASDAI score was higher (P < 0.05), SF-36 pain and physical scores, and chest expansion measurement were lower (P = 0.00, P = 0.01, P = 0.01), duration of morning stiffness was longer (P = 0.01) in patients with MGI. Serum C-reactive protein, erytrocyte sedimentation rate levels were similar between groups (P > 0.05). There is high prevalence of histological gut inflammation in AS patients. More active disease should suggest gut inflammation in AS patients.
Literature
4.
go back to reference Lee YH, Ji JD, Kim JS et al (1997) Ileocolonoscopic and histologic studies of Korean patients with ankylosing spondylitis. Scand J Rheumatol 26:473–476PubMedCrossRef Lee YH, Ji JD, Kim JS et al (1997) Ileocolonoscopic and histologic studies of Korean patients with ankylosing spondylitis. Scand J Rheumatol 26:473–476PubMedCrossRef
7.
go back to reference Mielants H, De Vos M, Cuvelier C, Veys EM (1996) The role of gut inflammation in the pathogenesis of spondyloarthropathies. Acta Clin Belg 51:340–349PubMed Mielants H, De Vos M, Cuvelier C, Veys EM (1996) The role of gut inflammation in the pathogenesis of spondyloarthropathies. Acta Clin Belg 51:340–349PubMed
8.
10.
go back to reference Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in anklosing spondylitis: the development of the bath anklosing spondilitis functional index. J Rheumatol 21:2281–2285PubMed Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in anklosing spondylitis: the development of the bath anklosing spondilitis functional index. J Rheumatol 21:2281–2285PubMed
12.
go back to reference Mielants H, Veys EM, Cuvelier C et al (1995) The evolution of spondyloarthropathies in relation to gut histology. Part II: histological aspects. J Rheumatol 22:2273–2278PubMed Mielants H, Veys EM, Cuvelier C et al (1995) The evolution of spondyloarthropathies in relation to gut histology. Part II: histological aspects. J Rheumatol 22:2273–2278PubMed
14.
go back to reference Falkenbach A, Franke A, van der Linden S (2003) Factors associated with body function and disability in patients with ankylosing spondylitis: a cross-sectional study. J Rheumatol 30:2186–2192PubMed Falkenbach A, Franke A, van der Linden S (2003) Factors associated with body function and disability in patients with ankylosing spondylitis: a cross-sectional study. J Rheumatol 30:2186–2192PubMed
16.
go back to reference Mielants H, Veys EM, Goethals K et al (1991) Gut inflammation in the spondyloarthropathies:clinical, radiological, biologic and genetic features in relation to the type of histology. A prospective study. J Rheumatol 18(10):1542–1551PubMed Mielants H, Veys EM, Goethals K et al (1991) Gut inflammation in the spondyloarthropathies:clinical, radiological, biologic and genetic features in relation to the type of histology. A prospective study. J Rheumatol 18(10):1542–1551PubMed
17.
go back to reference De Vos M, Cuvelier C, Mielants H et al (1990) Iliocolonoscopy in seronegative spondylarthropathy. Gastroenterology 98(4):1105–1106 De Vos M, Cuvelier C, Mielants H et al (1990) Iliocolonoscopy in seronegative spondylarthropathy. Gastroenterology 98(4):1105–1106
18.
go back to reference Mielant H, Veys EM (1996) Significance of intestinal inflammation in the pathogenesis of spondyloarthropathies. Verh K Acad Geneeskd Belg 58(2):93–116 Mielant H, Veys EM (1996) Significance of intestinal inflammation in the pathogenesis of spondyloarthropathies. Verh K Acad Geneeskd Belg 58(2):93–116
19.
go back to reference Smale S, Natt RS, Orchard TR, Russell AS, Bjarnason I (2001) Inflammatory bowel disease and spondylarthropathy. Arthritis Rheum 44:2728–2736. doi:10.1002/1529-0131(200112)44:12<2728::AID-ART459>3.0.CO;2-8PubMedCrossRef Smale S, Natt RS, Orchard TR, Russell AS, Bjarnason I (2001) Inflammatory bowel disease and spondylarthropathy. Arthritis Rheum 44:2728–2736. doi:10.1002/1529-0131(200112)44:12<2728::AID-ART459>3.0.CO;2-8PubMedCrossRef
Metadata
Title
Association of macroscopic gut inflammation with disease activity, functional status and quality of life in ankylosing spondylitis
Authors
Gulen Hascelik
Bengi Oz
Nese Olmez
Asuman Memis
Gazi Yoruk
Belkıs Unsal
Nese Ekinci
Publication date
01-05-2009
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 7/2009
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0766-6

Other articles of this Issue 7/2009

Rheumatology International 7/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine